Roussel Uclaf: Difference between revisions
Content deleted Content added
No edit summary |
m Robot: Automated text replacement (-{{[Cc]orp-stub}} +{{company-stub}}) |
||
| Line 3: | Line 3: | ||
Although it has more than 10,000 patents worldwide, Roussel Uclaf is best known for [[mifepristone]], otherwise known by its laboratory name of '''Compound 486'''. The US patent rights for this drug were donated to Population Council, Inc., a not-for-profit corporation in the USA, in 1994. |
Although it has more than 10,000 patents worldwide, Roussel Uclaf is best known for [[mifepristone]], otherwise known by its laboratory name of '''Compound 486'''. The US patent rights for this drug were donated to Population Council, Inc., a not-for-profit corporation in the USA, in 1994. |
||
{{ |
{{company-stub}} |
||
Revision as of 23:11, 23 February 2006
Roussel Uclaf is a French company, headquartered in Romainville. They are involved in healthcare, agro-chemical, animal health and related fields, although in 1994, many of their non-core activities were transferred to Hoechst Schering AgrEvo GmBH in Germany.
Although it has more than 10,000 patents worldwide, Roussel Uclaf is best known for mifepristone, otherwise known by its laboratory name of Compound 486. The US patent rights for this drug were donated to Population Council, Inc., a not-for-profit corporation in the USA, in 1994.
 | This corporation or company article is a stub. You can help Wikipedia by expanding it. |